Physician profile
Katherine Storms
NPI 1902213549
$793.20
in general payments reported to CMS, 2019-2025
9 companies · $84.54 in 2025
The $84.54 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $143 · 2024: $430 · 2025: $84.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $226.92 | 2024 | Breztri, Airsupra |
| Amgen INC. | $196.85 | 2023-2024 | Repatha, Evenity |
| Corcept Therapeutics | $114.30 | 2024 | Korlym |
| Cochlear Americas | $84.54 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Bayer Healthcare Pharmaceuticals INC. | $77.62 | 2022 | |
| Abbvie INC. | $34.17 | 2022 | |
| Daiichi Sankyo INC. | $24.21 | 2022 | |
| Abbott Laboratories | $20.86 | 2023 | Freestyle Libre 2 |
| Pfizer INC. | $13.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Storms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.